SurgiMab
PrivateLast Round
VC Round
May 9, 2018
Total Funding Raised
$1.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SurgiMab is a biotechnology company that develops injectable fluorescent conjugates to be used during fluorescence-guided surgery as in-vivo diagnostic agents to visualize tumors in real-time.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SurgiMab Comparables
Compare SurgiMab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blaze Bioscience, Inc. | 84% | |
| Vergent Bioscience | 83% | |
| On Target Laboratories | 80% | |
SurgiMab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 9, 2018 | ||||
| Seed | Sep 18, 2011 |
SurgiMab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abalis Finance AG | Seed, VC Round |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 304% MoM.
- Jan 27, 2026
Monthly visitors increased 123% MoM.
SurgiMab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SurgiMab's valuation, stock price, and market status.